Real-world implementation of AI in mammography

 

Artificial Intelligence (AI) is revolutionizing breast imaging. The real-world implementation of AI in mammography is being used to improve not only radiologist workflows but patient outcomes.

Samir Patel, MD, CCD, DABR, FACR, diagnostic radiologist at Radiology Inc. and Beacon Health System, spoke with Health Imaging about the growing trends of AI in mammography in sessions at the Radiological Society of North America (RSNA) 2023 meeting.

"There are over 500 FDA approved algorithms for AI just in radiology, and one of the most common areas where AI is starting to show its effect benefit is in breast imaging, specifically screening mammography. There was a survey a couple years ago from the American College of Radiology asking radiologists about their utilization of AI. In 2021, two-thirds of individuals were actually not using any algorithms. But my guess is even in two years, that number has probably changed. The most common subspecialty using AI was breast imaging. I think it's still starting to penetrate the marketplace. I would say as a field right now, it's still in the early adopter phase. But, I feel people are moving rapidly on the technology adoption curve, a lot faster than when they moved from film to digital or digital to tomosynthesis. I have a feeling from tomo to AI-assisted tomo, that lead time is going to be less and less," Patel explained. 

He said there are about 20 FDA-cleared AI applications just in breast imaging, and most of these were displayed by vendors on the expo floor at RSNA.

Addressing common mammography challenges

The implementation of AI in breast imaging addresses several common challenges faced by radiologists. For starters, Patel said the movement to tomosythnesis mammography has rapidly created an overwhelming number of images to analyze. Several breast imaging experts have told Health Imaging that AI will likely play a critical roll in helping sort through this massive uptick in images.

"Standard mammogram would only be four pictures back in the days of film and early digital, but now with tomosynthesis, that same study can can involve over 200 images. Multiply that times 50, 75, or 100 cases a day, and that is a massive volume of images to look at. The good news is now there are some algorithms out there to actually reduce those number of tomosynthesis images to be reviewed," Patel said. 

He added that AI can help do a first pass of the tomography image dataset to flag which slices appear to have an area of interest with a possible cancer. This can reduce the number of images a radiologist need to review.

"With physician burnout being so prevalent, some of these algorithms now actually reduce the number of images that radiologists would need to look at in order to detect breast cancers. Some algorithms reduce the number of images by up to two thirds without any loss of the ability to detect breast cancer," Patel explained.

AI can triage the exams, prioritizing reports with suspected critical findings for radiologists to review promptly. This helps the reader focusing on critical cases and better plan their workflow for the day. Many FDA-cleared algorithms can automatically perform measurements of breast lesions and assess mammograms for breast density BI-RADS scores.

Patel said this helps remove the great amount of variability between readers and can help save additional time when reviewing exams, adding that AI algorithms can also be used to improve image quality by reducing artifacts, eliminating the need for manual adjustments by radiologists.

Considerations for AI algorithm adoption

Patel emphasized the importance of strategic thinking before adopting AI algorithms. Identifying specific problems or areas in need of improvement should precede the adoption of an AI. He cautioned against acquiring algorithms without a clear problem statement, considering the associated costs and the limited resources of time and money.

One of the big concerns he sees is people getting an AI algorithm first when there really was not necessarily a problem to solve. 

"When we talk about algorithms, it can potentially be overwhelming with so many algorithms. These algorithms also come at a cost, so there is a price, a dollar figure to pay. So I think it's important that before they start thinking about algorithms, they should think about what problem or opportunity they're really trying to solve, or what opportunities are there for improvement," he noted.


 

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.